Sangamo Therapeutics
SGMO
#6363
Rank
โ‚ฌ0.55 B
Marketcap
2,68ย โ‚ฌ
Share price
2.14%
Change (1 day)
855.54%
Change (1 year)

Earnings for Sangamo Therapeutics (SGMO)

Earnings in 2024 (TTM): -โ‚ฌ0.2 Billion

According to Sangamo Therapeutics 's latest financial reports the company's current earnings are โ‚ฌ12.27 Million. In 2023 the company made an earning of -โ‚ฌ0.12 Billion, an increase over its 2022 earnings that were of -โ‚ฌ0.19 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Sangamo Therapeutics from 2000 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -โ‚ฌ0.2 Billion72.42%
2023 -โ‚ฌ0.12 Billion-40.88%
2022 -โ‚ฌ0.19 Billion9.79%
2021 -โ‚ฌ0.18 Billion41.52%
2020 -โ‚ฌ0.13 Billion23.17%
2019 -โ‚ฌ98.05 Million36.33%
2018 -โ‚ฌ71.92 Million36.89%
2017 -โ‚ฌ52.54 Million-22.32%
2016 -โ‚ฌ67.64 Million54.86%
2015 -โ‚ฌ43.68 Million75.62%
2014 -โ‚ฌ24.88 Million0.13%
2013 -โ‚ฌ24.84 Million
2011 -โ‚ฌ33.4 Million43.66%
2010 -โ‚ฌ23.25 Million28.52%
2009 -โ‚ฌ18.09 Million-23.55%
2008 -โ‚ฌ23.66 Million2.45%
2007 -โ‚ฌ23.1 Million19.5%
2006 -โ‚ฌ19.33 Million50.78%
2005 -โ‚ฌ12.82 Million75%
2004 -โ‚ฌ7.33 Million-33.25%
2003 -โ‚ฌ10.98 Million-62.27%
2002 -โ‚ฌ29.08 Million102.82%
2001 -โ‚ฌ14.34 Million23.21%
2000 -โ‚ฌ11.64 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
โ‚ฌ1.43 B-844.93%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚ฌ0.18 Billion-9.48%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ4.36 B-2,366.29%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ1.22 B-736.39%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ0.95 B-598.40%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ17.14 B-9,009.67%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ0.36 B-289.60%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ15.37 B-8,086.98%๐Ÿ‡บ๐Ÿ‡ธ USA